Skip to main content

Pfizer says the FDA has approved its migraine nasal spray Zavzpret

By CBS News  
   March 14, 2023

Zavzpret, a branded formulation of the generic drug zavegepant, is the "first and only" calcitonin gene-related peptide receptor antagonist nasal spray for treating migraines with or without an aura, or sensory disturbances such as flashes of light that can accompany a migraine.

Full story

Get the latest on healthcare leadership in your inbox.